Cardiac Disease of Raptors.

Cardiac disease, in its various presentations, is being recognized as a common raptor health problem. Evidence suggests that the prevalence of cardiac disease varies between captive and wild bird of prey populations, probably because of differences in activity levels and diet. However, a wide variety of cardiovascular diseases have been reported to affect raptor species (captive and free living), including atherosclerosis, pathogenic arrhythmias, infectious cardiomyopathies, and endocarditis. Diagnostic testing used to identify cardiac abnormalities include radiographic imaging, electrocardiogram, echocardiogram, and computed tomography angiograms. Information pertaining to therapeutic treatment for raptor cardiac disease patients is inadequate or has not been investigated. This review of cardiac disease will provide current information regarding cardiac diseases that are diagnosed in birds of prey, diagnostic testing, and treatment options.

The Educated Guess: Determining Drug Doses in Exotic Animals Using Evidence-Based Medicine.

Lack of species-specific pharmacokinetic and pharmacodynamic data is a challenge for pharmaceutical and dose selection. If available, dose extrapolation can be accomplished via basic equations. If unavailable, several methods have been described. Linear scaling uses an established milligrams per kilograms dose based on weight. This does not allow for differences in species drug metabolism, sometimes resulting in toxicity. Allometric scaling correlates body weight and metabolic rate but fails for drugs with significant hepatic metabolism and cannot be extrapolated to avians or reptiles. Evidence-based veterinary medicine for dose design based on species similarity is discussed, considering physiologic differences between classes.